QIA/ NL0015001WM6 /
2024-05-27 4:51:22 PM | Chg. +0.0500 | Volume | Bid5:35:39 PM | Ask7:48:28 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
40.2800EUR | +0.12% | 871 Turnover: 35,025.2100 |
40.2000Bid Size: 2,500 | 40.4250Ask Size: 80 | 9.19 bill.EUR | - | - |
GlobeNewswire
05-14
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire
05-13
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire
05-07
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire
05-02
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire
04-29
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
GlobeNewswire
04-24
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire
04-10
Questex’s IHIF EMEA 2024: The Meeting Place of Hospitality Innovators and Game-Changers
GlobeNewswire
04-03
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire
03-25
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire
03-18
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...
GlobeNewswire
02-27
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
GlobeNewswire
02-27
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire
02-15
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire
02-06
QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved op...
GlobeNewswire
01-25
QIAGEN announces partnership with Penn State University to advance microbiome sciences
GlobeNewswire
01-18
QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 mi...
GlobeNewswire
01-08
QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Sy...